Cerevel Therapeutics Holdings, Inc. Price to Free Cash Flow Ratio 2021-2024 | CERE
Historical price to free cash flow ratio values for Cerevel Therapeutics Holdings, Inc. (CERE) since 2021.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-07-31 | 44.96 | 0.00 | |
| 2024-03-31 | 42.27 | $-2.19 | 0.00 |
| 2023-12-31 | 42.40 | $-2.14 | 0.00 |
| 2023-09-30 | 21.83 | $-2.16 | 0.00 |
| 2023-06-30 | 31.79 | $-2.21 | 0.00 |
| 2023-03-31 | 24.39 | $-2.10 | 0.00 |
| 2022-12-31 | 31.54 | $-1.96 | 0.00 |
| 2022-09-30 | 28.26 | $-1.82 | 0.00 |
| 2022-06-30 | 26.44 | $-1.54 | 0.00 |
| 2022-03-31 | 35.01 | $-1.53 | 0.00 |
| 2021-12-31 | 32.42 | $-1.38 | 0.00 |
| 2021-09-30 | 29.50 | $-1.41 | 0.00 |
| 2021-06-30 | 25.62 | $-2.56 | 0.00 |
